Revive Therapeutics Ltd (RVVTF)

[ReviveThomas]

As I have predicted, the shutting down of infrastructure is leading to localized spread of infections, whereas when the world was completely connected pre-covid, these local infections were pushed aside by fewer, more dominant strains. Now after infrastructure is reopened and our social connections go back up, these localized strains are now able to spread. So essentially, instead of multiple communities being able to share a dominant strain and with that a dominant immunity, they are now spreading multiple strains after the re-opening. So be it covid or not, we are likely going to see a lot of new colds and infections that would otherwise have been unable to spread due to the existense of singular, dominant strains of infections.
Either way you look at it, it's a good time to be in the infectious disease business. And that's what bucillamine is being trialed for, with a specialty on Coronavirus, but it will be applicable to all infectious diseases, I believe.

EDIT: Time is also a factor in this regard. Where social distancing increases, viruses have not only smaller regions to breed and mutate, but also more time to evolve.